Evidence map›Paper›PMID 22227882›Full record

ArticleCalcified tissue international2012

A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.

Alun Hughes, Jennifer Kleine-Albers, Miep H Helfrich, Stuart H Ralston, Michael J Rogers

Open access · hybridAbstract read
In one paragraph

Article in Calcified tissue international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Semaphorin3E/plexinD1 Axis in Asthma: What We Know So Far!Advances in experimental medicine and biology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Osteoblast migration in vertebrate bone.Biological reviews of the Cambridge Philosophical Society · 2018
    Review
  10. Review
  11. Article
  12. Class 3 semaphorins are transcriptionally regulated by 1,25(OH)The Journal of steroid biochemistry and molecular biology · 2017
    Article
  13. Bone, brain & beyond.Reviews in endocrine & metabolic disorders · 2015
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alun HughesMusculoskeletal Research Programme, School of Medicine & Dentistry, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, UK. mmd403@yahoo.co.uk
Jennifer Kleine-Albers
Miep H Helfrich
Stuart H Ralston
Michael J Rogers
Institute of Medical Sciences · INUniversity of Aberdeen · GBWestern General Hospital · GB

Funding

Arthritis Research UK 17285Versus Arthritis 17285
6 · The paper itself

Abstract

Originally identified as axonal guidance cues, semaphorins are expressed throughout many different tissues and regulate numerous non-neuronal processes. We demonstrate that most class III semaphorins are expressed in mouse osteoblasts and are differentially regulated by cell growth and differentiation: Sema3d expression is increased and Sema3e expression decreased during proliferation in culture, while expression of Sema3a is unaffected by cell density but increases in cultures of mineralizing osteoblasts. Expression of Sema3a, -3e, and -3d is also differentially regulated by osteogenic stimuli; inhibition of GSK3β decreased expression of Sema3a and -3e, while 1,25-(OH)(2)D(3) increased expression of Sema3e. Parathyroid hormone had no effect on expression of Sema3a, -3b, or -3d. Osteoblasts, macrophages, and osteoclasts express the Sema3e receptor PlexinD1, suggesting an autocrine and paracrine role for Sema3e. No effects of recombinant Sema3e on osteoblast proliferation, differentiation, or mineralization were observed; but Sema3e did inhibit the migration of osteoblasts in a wound-healing assay. The formation of multinucleated, tartrate-resistant acid phosphatase-positive osteoclasts was decreased by 81% in cultures of mouse bone marrow macrophages incubated with 200 ng/mL Sema3e. Correspondingly, decreased expression of osteoclast markers (Itgb3, Acp5, Cd51, Nfatc1, CalcR, and Ctsk) was observed by qPCR in macrophage cultures differentiated in the presence of Sema3e. Our results demonstrate that class III semaphorins are expressed by osteoblasts and differentially regulated by differentiation, mineralization, and osteogenic stimuli. Sema3e is a novel inhibitor of osteoclast formation in vitro and may play a role in maintaining local bone homeostasis, potentially acting as a coupling factor between osteoclasts and osteoblasts.

Indexed as

AnimalsBlotting, WesternCell DifferentiationCell MovementCells, CulturedCytoskeletal ProteinsGlycoproteinsMembrane ProteinsMiceMice, Inbred C57BLOsteoblastsOsteoclastsRabbitsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSemaphorinsCytoskeletal ProteinsGlycoproteinsMembrane ProteinsSema3e protein, mouseSemaphorins

Identifiers

PMID22227882
PMCPMC3271215
OpenAlexW2143107468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.